[The clinical aspects of using thrombolytic therapy in myocardial infarct at the prehospital stage].
The examination of 80 patients with acute myocardial infarction has revealed that prehospital thrombolytic therapy (TT) allows it to be initiated significantly earlier by 2.9 hours, resulting in coronary reperfusion and ensuring more complete blood flow recovery than hospital therapy. The natural history of the disease is also more favourable when TT is used in the prehospital period. It is concluded that with strict observance of indications and contraindications, TT used by an emergency team in the prehospital period is no more dangerous than in the hospital period.
Staroverov
I I
II
Dundua
D P
DP
Plotnikov
A N
AN
Pomerantsev
E V
EV
Bliumental'
A A
AA
Puchkov
A T
AT
Ovasapian
Iu A
IuA
Serov
V P
VP
Ruda
M Ia
MIa
D000368:Aged; D017023:Coronary Angiography; D004341:Drug Evaluation; D004562:Electrocardiography / Q000187:drug effects; D004630:Emergencies; D005260:Female; D005392:First Aid; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000009:adverse effects; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D011994:Recombinant Proteins; D013300:Streptokinase; D010959:Tissue Plasminogen Activator